Balveen Kaur

Solid Tumor Biology Program, The Ohio State University Medical Center

Affiliated withThe Ohio State University Medical Center

Research Area

Biography

Balveen Kaur has not added Biography.
If you are Balveen Kaur and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 13	2014

Other Publications

Article	Year
Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Advances in anatomic pathology\| PubMed ID: 11756757	2002
Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer research\| PubMed ID: 11980636	2002
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. Cancer research\| PubMed ID: 12019170	2002
Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Frontiers in bioscience : a journal and virtual library\| PubMed ID: 12456339	2003
Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. The American journal of pathology\| PubMed ID: 12507886	2003
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer research\| PubMed ID: 14871821	2004
Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15623644	2004
Genetic and hypoxic regulation of angiogenesis in gliomas. Journal of neuro-oncology\| PubMed ID: 15674480	2004
Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene\| PubMed ID: 15782143	2005
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-oncology\| PubMed ID: 15831232	2005
Gene therapeutics: the future of brain tumor therapy? Expert review of anticancer therapy\| PubMed ID: 16831077	2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16908838	2006
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 16996314	2006
Personalizing oncolytic virotherapy? Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 17164767	2007
Oncolytic viruses driven by tumor-specific promoters. Current cancer drug targets\| PubMed ID: 17346110	2007
Oncolytic viruses: extreme treatment for an extreme disease. Future microbiology\| PubMed ID: 17661625	2006
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer research\| PubMed ID: 17909049	2007
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. Journal of the National Cancer Institute\| PubMed ID: 18042934	2007
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 18545226	2008
Advances in oncolytic virus therapy for glioma. Recent patents on CNS drug discovery\| PubMed ID: 19149710	2009
Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. Cancer research\| PubMed ID: 19176395	2009
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of neuro-oncology\| PubMed ID: 19381449	2009
Pharmacologic and chemical adjuvants in tumor virotherapy. Chemical reviews\| PubMed ID: 19462957	2009
Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19844198	2010
"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment. Current gene therapy\| PubMed ID: 19860649	2009
Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin. The American journal of pathology\| PubMed ID: 20167858	2010
Directing systemic oncolytic viral delivery to tumors via carrier cells. Cytokine & growth factor reviews\| PubMed ID: 20226717	2010
Impact of tumor microenvironment on oncolytic viral therapy. Cytokine & growth factor reviews\| PubMed ID: 20399700	2010
Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21177410	2011
Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments. Cancer research\| PubMed ID: 21697283	2011
Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress. Current pharmaceutical biotechnology\| PubMed ID: 21740359	2012
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21844505	2011
Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22031239	2012
Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer research\| PubMed ID: 22282654	2012
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Advances in virology\| PubMed ID: 22312364	2012
The HDAC inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells with inhibition of STAT5/T-BET signaling and IFNÎ³ generation. Journal of virology\| PubMed ID: 22318143	2012
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22431589	2012
Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22753591	2012
Extracellular vesicles and their convergence with viral pathways. Advances in virology\| PubMed ID: 22888349	2012
Anti-angiogenic gene therapy in the treatment of malignant gliomas. Neuroscience letters\| PubMed ID: 22906922	2012
Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology : official journal of the Japanese Society of Neuropathology\| PubMed ID: 22989076	2013
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 23070115	2013
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature medicine\| PubMed ID: 23178246	2012
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 23481323	2013
How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma? Expert review of neurotherapeutics\| PubMed ID: 23545048	2013
Gene expression profiling of the anti-glioma effect of Cilengitide. SpringerPlus\| PubMed ID: 23667810	2013
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer research\| PubMed ID: 23729642	2013
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 23732993	2013
Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density. The Journal of biological chemistry\| PubMed ID: 23782696	2013
STAT3 activation promotes oncolytic HSV1 replication in glioma cells. PloS one\| PubMed ID: 23936533	2013
Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PloS one\| PubMed ID: 24039814	2013
DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24056786	2013
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma. Cancer research\| PubMed ID: 24453002	2014